Diphtheria-Tetanus-Pertussis Vaccine
"Diphtheria-Tetanus-Pertussis Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A vaccine consisting of DIPHTHERIA TOXOID; TETANUS TOXOID; and whole-cell PERTUSSIS VACCINE. The vaccine protects against diphtheria, tetanus, and whooping cough.
| Descriptor ID |
D015721
|
| MeSH Number(s) |
D20.215.894.135.535.300 D20.215.894.691.263.300 D20.215.894.691.824.300 D20.215.894.815.300
|
| Concept/Terms |
Diphtheria-Tetanus-Pertussis Vaccine- Diphtheria-Tetanus-Pertussis Vaccine
- Diphtheria Tetanus Pertussis Vaccine
- Vaccine, Diphtheria-Tetanus-Pertussis
- DTwP Vaccine
- Vaccine, DTwP
- DPT Vaccine
- Vaccine, DPT
- DTP Vaccine
- Vaccine, DTP
- Di-Te-Per Vaccine
- Di Te Per Vaccine
- Vaccine, Di-Te-Per
- Diphtheria-Pertussis-Tetanus Vaccine
- Diphtheria Pertussis Tetanus Vaccine
- Vaccine, Diphtheria-Pertussis-Tetanus
|
Below are MeSH descriptors whose meaning is more general than "Diphtheria-Tetanus-Pertussis Vaccine".
Below are MeSH descriptors whose meaning is more specific than "Diphtheria-Tetanus-Pertussis Vaccine".
This graph shows the total number of publications written about "Diphtheria-Tetanus-Pertussis Vaccine" by people in this website by year, and whether "Diphtheria-Tetanus-Pertussis Vaccine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diphtheria-Tetanus-Pertussis Vaccine" by people in Profiles.
-
Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial. Vaccine. 2021 03 05; 39(10):1534-1543.
-
Vaccine adverse events in a safety net healthcare system and a managed care organization. Vaccine. 2017 03 01; 35(9):1335-1340.
-
Lot-to-lot Consistency, Safety, Tolerability and Immunogenicity of an Investigational Hexavalent Vaccine in US Infants. Pediatr Infect Dis J. 2017 02; 36(2):202-208.
-
Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis. Clin Infect Dis. 2016 Dec 01; 63(11):1456-1462.
-
Safety of DTaP-IPV/Hib vaccine administered routinely to infants and toddlers. Vaccine. 2016 07 29; 34(35):4172-4179.
-
A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput Biol. 2015 Apr; 11(4):e1004138.
-
Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA. 2014 May 07; 311(17):1760-9.
-
Safety of diphtheria, tetanus, acellular pertussis and inactivated poliovirus (DTaP-IPV) vaccine. Vaccine. 2014 May 23; 32(25):3019-24.
-
Adapting group sequential methods to observational postlicensure vaccine safety surveillance: results of a pentavalent combination DTaP-IPV-Hib vaccine safety study. Am J Epidemiol. 2013 Jan 15; 177(2):131-41.
-
Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012 Sep 13; 367(11):1012-9.